Becker's Healthcare November 22, 2022
In Collaboration with Capital Rx

The Consolidated Appropriations Act (CAA) of 2021 is long overdue legislation aiming to improve prescription drug price transparency and shed light on the role of pharmacy benefit managers (PBMs).

During the Payer Issues Roundtable hosted by Becker’s Hospital Review, in a session sponsored by Capital Rx, a pharmacy benefit manager and a pharmacy benefit administrator, Phil Vecchiolli, senior vice president and general manager of PBA services at Capital Rx, moderated a discussion with the company’s president, Matthew Gibbs, about drawbacks of the legislation and steps organizations can take to prepare for compliance.

Three key takeaways were:

  1. The CAA provides a framework for how drug procurement should work in the future. It mandates that employer-based health plans and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Employer, Insurance, Pharma, Pharma / Biotech, Trends
CDC: Thanks in part to fewer COVID-19 deaths, life expectancy rises slightly from 2021 to 2022
Cross-country comparison in health care price growth: 2000-2020
Health Reimbursement Arrangements: An Option for Small Employers
Empowering Employer Purchasers: Recommendations To Support Market Transparency And Health System Performance
Insights on Leading Employers in Top Business Sectors and Insurers that Serve Them by Mark Farrah Associates

Share This Article